Resveratrol nasal spray — Competitive Intelligence Brief

Resveratrol nasal spray (Resveratrol nasal spray) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Polyphenolic antioxidant. Area: Neurology, Inflammation, Respiratory.

phase 3 Polyphenolic antioxidant SIRT1, NF-κB pathway Neurology, Inflammation, Respiratory Small molecule

Target snapshot

Resveratrol nasal spray (Resveratrol nasal spray) — University of Campania Luigi Vanvitelli. Resveratrol is a polyphenolic antioxidant that activates sirtuins and other cellular pathways to reduce inflammation and oxidative stress.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Resveratrol nasal spray TARGET	Resveratrol nasal spray	University of Campania Luigi Vanvitelli	phase 3	Polyphenolic antioxidant	SIRT1, NF-κB pathway
Mega Resveratrol® capsules	Mega Resveratrol® capsules	Sun Yat-sen University	phase 3	Polyphenolic antioxidant / Sirtuin activator	SIRT1, general antioxidant pathways, AMPK

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Polyphenolic antioxidant class)

1. University of Campania Luigi Vanvitelli · 1 drug in this class